Platelet-activating factor (PAF)--a putative mediator in inflammatory tissue injury.
Yue
T L
TL
Department of Pharmacology, SmithKline Beecham Pharmaceuticals, King of Prussia, PA 19406-0939.
Rabinovici
R
R
Feuerstein
G
G
D000818:Animals; D001792:Blood Platelets / Q000502:physiology; D016207:Cytokines / Q000378:metabolism; D006801:Humans; D007249:Inflammation / Q000503:physiopathology*; D015289:Leukotrienes / Q000378:metabolism; D010972:Platelet Activating Factor / Q000737:chemistry / Q000378:metabolism / Q000502:physiology*; D010980:Platelet Membrane Glycoproteins; D011453:Prostaglandins / Q000378:metabolism; D011956:Receptors, Cell Surface / Q000502:physiology; D043562:Receptors, G-Protein-Coupled; D015427:Reperfusion Injury / Q000503:physiopathology; D015398:Signal Transduction
D016207:Cytokines; D015289:Leukotrienes; D010972:Platelet Activating Factor; D010980:Platelet Membrane Glycoproteins; D011453:Prostaglandins; D011956:Receptors, Cell Surface; D043562:Receptors, G-Protein-Coupled; C039351:platelet activating factor receptor